Furthermore, since FAK promotes tumor progression through effects on multiple cells of the tumor microenvironment (Sulzmaier et al., 2014; Trenti et al., 2018), interfering with the FAK signaling pathway may be a promising strategy to target invasive cancer types that are prevalent in women (Sood et al., 2004; Lark et al., 2005). This evidence concerns the gene PTK2 and cancer.